Clene Inc. (CLNN) - Dilution Analysis

10-Q filing | 11.6M shares outstanding

8-K filing: Clene Inc. entered into an underwriting agreement to issue and sell 1,000,000 shares of common stock at $7.00 per share, with net proceeds estimated at $6.4 million. ($7.0M proceeds)

8-K filing: Clene Inc. entered into a securities purchase agreement for the sale of 928,333 shares of common stock and warrants to purchase up to 3,713,333 shares, with the closing date on January 13, 2026. ($6.03M proceeds)

10-Q filing | 10.3M shares outstanding

S-3 filing: This prospectus relates to the offer and resale of common stock issuable upon conversion of senior secured convertible promissory notes.

10-Q filing | 9.5M shares outstanding

10-Q filing | 8.8M shares outstanding

8-K filing: Clene Inc. issued 35,311 shares of common stock at a price of $3.54 per share to fully satisfy outstanding indebtedness of $125,000. ($0.13M proceeds)

S-3 filing: The filing is for a shelf offering of common stock, preferred stock, debt securities, warrants, and/or units up to an aggregate amount of $160,000,000.

10-K filing | 8.1M shares outstanding

S-3 filing: This prospectus relates to the offer and resale of up to 1,146,789 shares of common stock, that may be issued upon the conversion of senior secured convertible promissory notes.

10-Q filing | 6.6M shares outstanding

S-3 filing: This prospectus relates to the offer and resale, from time to time by the Selling Securityholders, of shares of our common stock issuable upon the exercise of warrants and shares of our common stock originally issued as part of three separate, concurrent private placements.

8-K filing: Clene Inc. amended its loan agreement with Avenue Venture Opportunities Fund, L.P., and amended and restated a warrant to purchase 150,000 shares of common stock, updating the exercise price to $4.6014 per share.

8-K filing: Clene Inc. entered into securities purchase agreements for the sale of registered shares, pre-funded warrants, and restricted warrants in concurrent private placements, with the offering expected to close on or about October 1, 2024.

10-Q filing | 6.4M shares outstanding

8-K filing: Stock split 1-for-20 | Outstanding: 128,427,231 → 6,400,000

10-Q filing | 128.4M shares outstanding

10-K filing | 128.4M shares outstanding

10-Q filing | 128.4M shares outstanding

S-3/A filing: This prospectus relates to the offer and resale from time to time by the Selling Securityholder, of up to an aggregate of 3,000,000 shares of Clene Inc. common stock that may be issued upon the exercise of a warrant to purchase common stock at an exercise price of $0.80 per share.

S-3 filing: This prospectus relates to the issuance and resale of up to 3,000,000 shares of Clene Inc. common stock that may be issued upon the exercise of a warrant to purchase common stock at an exercise price of $0.80 per share.

10-Q filing | 128.4M shares outstanding

8-K filing: Clene Inc. entered into the Second Amendment to its Loan and Security Agreement with Avenue Venture Opportunities Fund, L.P., which includes the issuance of a warrant to purchase 3,000,000 shares of common stock in replacement of an earlier warrant.

8-K filing: Clene Inc. entered into an underwriting agreement to issue and sell 50,000,000 shares of common stock along with warrants in an equity offering, with each unit consisting of one share, one Tranche A Warrant, and one Tranche B Warrant, at a price of $0.80 per unit, with the offering expected to close on June 21, 2023. ($40.0M proceeds)

10-Q filing | 76.0M shares outstanding

10-K filing | 74.8M shares outstanding

8-K filing: Clene Inc. entered into a purchase agreement with Lincoln Park Capital Fund, LLC, for the sale of up to $25,000,000 of shares of the Company's common stock over a 36-month period.

10-Q filing | 73.8M shares outstanding

8-K filing: Clene Inc. entered into a securities purchase agreement to issue and sell 10,723,926 shares of common stock at $1.01 per share in a registered direct offering, with gross proceeds of approximately $10.8 million before expenses. ($10.8M proceeds)

10-Q filing | 63.3M shares outstanding

10-Q filing | 63.3M shares outstanding

S-3 filing: The filing is an S-3 shelf registration for up to $175,000,000 aggregate dollar amount of common stock, preferred stock, debt securities, warrants, and/or units consisting of some or all of these securities.

10-K filing | 63.1M shares outstanding

POS AM filing: This prospectus relates to the issuance of common stock upon exercise of warrants and the offer and resale of common stock by selling shareholders.

10-Q filing | 62.1M shares outstanding

10-Q filing | 61.5M shares outstanding

S-1 filing: This is an S-1 filing relating to the offer and sale of common stock by selling shareholders, as well as the issuance of common stock upon exercise of warrants.

8-K filing: Clene Inc. entered into a Loan and Security Agreement for up to $30 million and completed a private placement of 960,540 shares of common stock at $9.63 per share, resulting in net proceeds of approximately $9.25 million. ($9.25M proceeds)

10-Q filing | 59.6M shares outstanding

10-K filing | 59.5M shares outstanding

S-1/A filing: This S-1/A filing registers shares of common stock for sale by selling shareholders and shares issuable upon exercise of warrants.

S-1 filing: This S-1 filing registers the offer and sale of common stock to satisfy certain registration rights, including shares for selling shareholders and shares to be issued upon exercise of warrants.

8-K filing: Clene entered into agreements involving common stock, including an Escrow Agreement for 2,716,950 shares, Lock-Up Agreements for 36,854,068 shares, a Registration Rights Agreement for 19.3 million shares, and a Private Placement involving the sale of 2,239,500 shares and warrants for 1,119,750 shares. ($22.2M proceeds)